Pharmacokinetics of interferons. a reappraisal
Bocci, V.
Texas Reports on Biology and Medicine 41: 336-343
1981
ISSN/ISBN: 0040-4675 PMID: 6184823 Document Number: 176288
Document emailed within 1 workday
Related Documents
Petrenko, V.A.; Tat'kov, S.I.; Sivolobova, G.F.; Boldyrev, A.N.; Kolokol'tsev, A.A. 1987: Antiviral activity of mutant interferons. a new approach to the study of structural-functional organization of interferons Bioorganicheskaia Khimiia 13(2): 259-262Blétry, O.; Papo, T. 1993: Interferons. Interferons alpha and gamma: indications in systemic diseases Annales de Medecine Interne 144(8): 557-562
Lobodzińska, M.; Biernacka, I.; Skurska, Z. 1973: Rat interferons. I. Biological properties of interferons in rat serum Archivum Immunologiae et Therapiae Experimentalis 21(3): 461-469
Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
Sedmak, J.J.; Grossberg, S.E. 1977: Stabilization of interferons Texas Reports on Biology and Medicine 35: 198-204
Zafar, M.N. 1982: Interferons: in vivo effects Jpma. Journal of the Pakistan Medical Association 32(8): 174-176
Roberts, R.M.; Cross, J.C.; Farin, C.E.; Hansen, T.R.; Klemann, S.W.; Imakawa, K. 1990: Interferons at the placental interface Journal of Reproduction and Fertility. Supplement 41: 63-74
Civeira, M.P. 1996: Clinical use of interferons in hepatology Methods and Findings in Experimental and Clinical Pharmacology 18 Suppl B: 33-34
Ludwig, C.U. 1989: Possibilities and limits of the use of interferons in the clinic Schweizerische Medizinische Wochenschrift 119(44): 1539-1543
Malashenkova, I.K.; Tazulakhova, E.B.; Didkovskiĭ, N.A. 1998: Interferons and inductors of their synthesis (review) Terapevticheskii Arkhiv 70(11): 35-39
Müller, R. 1991: Interferons in chronic viral hepatitis Hepato-Gastroenterology 38(1): 4-9
Filipic, B.; Golob, A.; Tóth, S.; Mécs, I.; Béládi, I.; Likar, M. 1991: Interactions between human and porcine interferons Acta Virologica 35(1): 19-26
Cooper, M.R. 1988: Interferons in the management of multiple myeloma Seminars in Oncology 15(5 Suppl 5: 21-25
Hosoi, K.; Kobayashi, S. 1984: Production and purification of human interferons Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(1): 16-23
Ucar, R.; Sanwo, M.; Ucar, K.; Beall, G. 1995: Interferons: their role in clinical practice Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 75(5): 377-386; Quiz: 386-389
Budzianowski, J. 2014: Tobacco - a producer of recombinant interferons Przeglad Lekarski 71(11): 639-643
Ahmed, A.; Ellsworth, P. 2012: To circ or not: a reappraisal Urologic Nursing 32(1): 10-18; Quiz 19